Adrenal disease

Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures

PituitaryPublished Cross-sectional study

Authors' conclusion

These results demonstrate a BOI in CS despite ongoing treatment and illustrate the need for interventions to address persistent symptoms, particularly weight gain, pain, and anxiety.

Study context

Population
Patients with endogenous Cushing's syndrome (CS) diagnosed ≥ 6 months prior who had received ≥ 1 treatment; 85% women, mean age 43.4 ± 12.3 years
Participants
55 patients
Outcome
Burden of illness from first symptoms through treatment
Methodological detailsweb-enabled survey, 5 validated patient reported outcomes (PRO) measures
  • Web-enabled survey
  • 5 validated PRO measures

Main finding

As reported in the abstract

Burden of illness
Mean gap between first symptoms and diagnosis
10 years
Underwent surgical treatment
80%
Days with symptoms in a typical month
16
Moderate or severe fatigue (Brief Fatigue Inventory)
69%
Participants reporting missed workdays due to CS symptoms
38%
Annual average missed workdays among them
25

Observational data: associations, not effects.

Original publication

Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures. Pituitary. Published 19 April 2023. doi:10.1007/s11102-023-01314-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.